Table 1.
Baseline clinical characteristics and kidney biopsy findings of patients with IgA Nephropathy.
Table 2.
Histological findings of thrombotic mycroangiopathy in renal biopsies of IgAN patients.
Table 3.
Laboratory findings of thrombotic microangiopathy in patients with and without histologic evidence of TMA.
Table 4.
Analysis of clinical parameters and laboratory findings in IgAN patients with and without histologic evidence of TMA.
Table 5.
Clinical parameters and laboratory findings of IgAN patients progressing or not to CKD-KRT.
Fig 1.
CD68 immunohistochemistry of kidney biopsies of IgAN patients labeled positive in the A) glomerulus (x400) and B) tubulointerstitium (x200). C) C4d immunohistochemistry revealing positive glomerular staining (x400).
Fig 2.
Survival free of dialysis of patients with IgAN with and without evidence of TMA in kidney biopsy specimens.
Table 6.
Logistic regression analysis for the primary outcomea adjusted for sex, hypertension, creatinine, Oxford classification parameters (M,E,S,T,C) and TMA.